Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06719375

Evaluation of Gait Impairment and Correlation in Patients With DCM

This study aims to evaluate gait impairment in patients with Degenerative Cervical Myelopathy (DCM) before and after surgery using an inertial measurement unit (IMU) sensor. By comparing IMU-derived gait parameters with traditional clinical assessment tools (e.g., Modified Ashworth Scale, mJOA, and GRASSP), the study seeks to determine the effectiveness and reliability of IMU sensors for assessing and monitoring gait improvement and neurological recovery in DCM patients. This study is conducted outside the United States and does not involve interventions or devices subject to U.S. FDA regulation.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

This observational study will investigate the correlation between gait parameters measured with an IMU sensor and established clinical evaluation tools for patients with Degenerative Cervical Myelopathy (DCM). The primary aim is to quantify gait impairments before and after surgical intervention and to verify the IMU sensor's utility as a quantitative assessment tool. The study will recruit both DCM patients and a control group to evaluate the sensitivity of the IMU sensor in detecting fine motor and gait differences. Outcomes will be analyzed using statistical comparisons of pre- and post-surgery measurements, with specific focus on gait speed, cadence, stride length, and spasticity. The anticipated goal is to validate the IMU sensor as a reliable alternative to existing clinical tools, facilitating early detection of gait impairment and monitoring post-surgical improvement in DCM patients. This study is conducted entirely outside the United States and does not involve interventions or devices subject to U.S. FDA regulation. The devices and procedures used in this study are approved by local regulatory authorities in the country where the study is conducted. The study complies with applicable international and local guidelines rather than U.S. FDA requirements.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older.
  • Able to communicate and provide informed consent.
  • Capable of walking at least 3 meters without assistance from others or walking aids.
  • No prior surgical treatment for cervical myelopathy.
  • Lower limb motor function score of 2 or higher on the mJOA scale.

Exclusion criteria

  • Presence of severe respiratory or cardiac conditions that impede safe walking.
  • Musculoskeletal issues, such as spinal deformities, affecting gait.
  • History of neurological disorders affecting gait, including peripheral nerve injury, joint stiffness, stroke, traumatic brain injury, myelitis, or Parkinson's disease.
  • Prior orthopedic or neurosurgical interventions that could impact gait.
  • Cervical conditions resulting from trauma (acute fracture or acute disc herniation), tumor, or infection.

Treatment and study plan

Gait Analysis Using IMU Sensor

Device

Inertial Measurement Unit (IMU) sensor-based 3D gait analysis to assess spasticity and gait impairment. This intervention aims to provide quantitative data on gait parameters in DCM patients before and after surgery.

Primary outcomes

  1. Step Length

    Time frame: 10 days before surgery, 10 days after surgery, and 30 days after surgery.

    Step length is measured in centimeters (cm) to independently evaluate the gait characteristics of patients with Degenerative Cervical Myelopathy (DCM). Step length is defined as the distance covered between two successive placements of the same foot and is a critical parameter to assess balance and mobility.

  2. Walking Speed

    Time frame: 10 days before surgery, 10 days after surgery, and 30 days after surgery.

    Walking speed is measured in kilometers per hour (km/h) to independently assess the gait characteristics of patients with Degenerative Cervical Myelopathy (DCM). Walking speed evaluates the efficiency of ambulation over a defined distance and is a vital measure of functional mobility.

  3. Stride Length

    Time frame: 10 days before surgery, 10 days after surgery, and 30 days after surgery.

    Stride length is measured in centimeters (cm) to independently evaluate the gait characteristics of patients with Degenerative Cervical Myelopathy (DCM). Stride length is defined as the distance covered in one complete gait cycle and provides insights into the patient's walking stability.

  4. Cadence

    Time frame: 10 days before surgery, 10 days after surgery, and 30 days after surgery.

    Cadence is measured in steps per minute (steps/min) to independently assess the gait characteristics of patients with Degenerative Cervical Myelopathy (DCM). Cadence represents the number of steps taken per minute and is used to analyze walking rhythm and patterns.

Secondary outcomes

  1. Modified Japanese Orthopaedic Association (mJOA) Score

    Time frame: 10 days before surgery, 10 days after surgery, and 30 days after surgery.

    The mJOA score is used to assess neurological function in patients with Degenerative Cervical Myelopathy (DCM). This score evaluates motor dysfunction, sensory dysfunction, and bladder function. The score ranges from 0 (worst outcome) to 18 (best outcome), with higher scores indicating better neurological function.

  2. Modified Ashworth Scale (MAS)

    Time frame: 10 days before surgery, 10 days after surgery, and 30 days after surgery.

    The MAS score is used to assess spasticity in patients with Degenerative Cervical Myelopathy (DCM). The scale ranges from 0 (no increase in muscle tone) to 4 (rigid in flexion or extension). Lower scores indicate better outcomes, reflecting reduced spasticity.

Study contacts

Contact information is provided by the study sponsor or research team.

Sungchul Huh, PhD

CONTACT

[email protected]

82-55-360-4250

Sungchul Huh, PhD

CONTACT

[email protected]

055-360-4250

Sponsors and collaborators

Lead sponsor

Pusan National University Yangsan Hospital

Other

Registry information

Official study title

Evaluation of Gait Impairment and Correlation With Clinical Assessment Tools Before and After Surgery in Patients With Cervical Myelopathy Using Inertial Sensors

Acronym: DCM-HFIMU

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Dec 5, 2024
Registry last updated
Jun 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.